Efficacy and Safety of IBI310 Combined with Sintilimab in Patients with Advanced Hepatocellular Carcinoma
Clinical trial NCT04401813 · COMPLETED
Trial details
- NCT number
- NCT04401813
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-16
- Primary completion
- 2024-06-21
- Enrollment
- 97
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.